Spinocerebellar Ataxia Type 3 Overview
Learn About Spinocerebellar Ataxia Type 3
View Main Condition: Movement Disorders
- Spinocerebellar ataxia 3
- Azorean neurologic disease
- MJD
- Machado-Joseph disease
- Nigrospinodentatal degeneration
- SCA3
- Spinocerebellar atrophy type 3
- Spinopontine atrophy
Jose Pedroso practices in Sao Paulo, Brazil. Mr. Pedroso is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 3. His top areas of expertise are Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia, Olivopontocerebellar Atrophy, and Drug Induced Dyskinesia.
Patricia Maciel practices in Braga, Portugal. Ms. Maciel is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 3. Her top areas of expertise are Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Striatonigral Degeneration Infantile.
Regents Of The University Of Michigan
Henry Paulson is a Neurologist in Ann Arbor, Michigan. Dr. Paulson is rated as an Elite provider by MediFind in the treatment of Spinocerebellar Ataxia Type 3. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is currently accepting new patients.
Summary: The goal of this first-in-human clinical trial is to assess the safety and tolerability of four doses of a new study drug called VO659 in people with genetic disorders called spinocerebellar ataxia type 1, type 3 or Huntington's disease. Another aim is to determine the concentrations of the study drug in the cerebral spinal fluid and blood after single and multiple doses. Study drug will be admini...
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center